MRS 2768 tetrasodium saltSelective P2Y2 agonist CAS# 1047980-83-5 |
2D Structure
- MTEP hydrochloride
Catalog No.:BCC1780
CAS No.:1186195-60-7
- mGlu2 agonist
Catalog No.:BCC1745
CAS No.:1311385-32-6
- LY341495
Catalog No.:BCC1724
CAS No.:201943-63-7
- CPPHA
Catalog No.:BCC1501
CAS No.:693288-97-0
- Dipraglurant
Catalog No.:BCC1531
CAS No.:872363-17-2
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 1047980-83-5 | SDF | Download SDF |
PubChem ID | 90488893 | Appearance | Powder |
Formula | C15H16N2O18P4Na4 | M.Wt | 728.14 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble in water (supplied pre-dissolved at a concentration of 10mM) | ||
Chemical Name | tetrasodium;[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] [oxido-[oxido(phenoxy)phosphoryl]oxyphosphoryl] phosphate | ||
SMILES | C1=CC=C(C=C1)OP(=O)([O-])OP(=O)([O-])OP(=O)([O-])OP(=O)([O-])OCC2C(C(C(O2)N3C=CC(=O)NC3=O)O)O.[Na+].[Na+].[Na+].[Na+] | ||
Standard InChIKey | ASYFBNZFGLWLNC-YYXHNCPRSA-J | ||
Standard InChI | InChI=1S/C15H20N2O18P4.4Na/c18-11-6-7-17(15(21)16-11)14-13(20)12(19)10(31-14)8-30-36(22,23)33-38(26,27)35-39(28,29)34-37(24,25)32-9-4-2-1-3-5-9;;;;/h1-7,10,12-14,19-20H,8H2,(H,22,23)(H,24,25)(H,26,27)(H,28,29)(H,16,18,21);;;;/q;4*+1/p-4/t10-,12-,13-,14-;;;;/m1..../s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Selective P2Y2 agonist (EC50 = 1.89 μM). Displays no affinity for human P2Y4 or P2Y6 receptors. |
MRS 2768 tetrasodium salt Dilution Calculator
MRS 2768 tetrasodium salt Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 1.3734 mL | 6.8668 mL | 13.7336 mL | 27.4672 mL | 34.3341 mL |
5 mM | 0.2747 mL | 1.3734 mL | 2.7467 mL | 5.4934 mL | 6.8668 mL |
10 mM | 0.1373 mL | 0.6867 mL | 1.3734 mL | 2.7467 mL | 3.4334 mL |
50 mM | 0.0275 mL | 0.1373 mL | 0.2747 mL | 0.5493 mL | 0.6867 mL |
100 mM | 0.0137 mL | 0.0687 mL | 0.1373 mL | 0.2747 mL | 0.3433 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- 4-O-Methylsappanol
Catalog No.:BCN5863
CAS No.:104778-16-7
- Sappanone B
Catalog No.:BCN7942
CAS No.:104778-15-6
- Plantamajoside
Catalog No.:BCN6279
CAS No.:104777-68-6
- 3alpha-Akebonoic acid
Catalog No.:BCN5862
CAS No.:104777-61-9
- Entacapone sodium salt
Catalog No.:BCC4107
CAS No.:1047659-02-8
- Afuresertib
Catalog No.:BCC5502
CAS No.:1047644-62-1
- GSK2141795 hydrochloride
Catalog No.:BCC5295
CAS No.:1047635-80-2
- GSK2141795
Catalog No.:BCC5294
CAS No.:1047634-65-0
- Strontium chloride
Catalog No.:BCC7973
CAS No.:10476-85-4
- Ganoderic acid S
Catalog No.:BCN5861
CAS No.:104759-35-5
- 4E-Deacetylchromolaenide 4'-O-acetate
Catalog No.:BCN7263
CAS No.:104736-09-6
- Mayteine
Catalog No.:BCN3098
CAS No.:104736-05-2
- Masitinib mesylate
Catalog No.:BCC1729
CAS No.:1048007-93-7
- COR 170
Catalog No.:BCC6282
CAS No.:1048039-15-1
- Alpha-Terpineol
Catalog No.:BCN8136
CAS No.:10482-56-1
- Germanicol acetate
Catalog No.:BCN7264
CAS No.:10483-91-7
- UPF 1069
Catalog No.:BCC2213
CAS No.:1048371-03-4
- NF 157
Catalog No.:BCC7367
CAS No.:104869-26-3
- NF 023
Catalog No.:BCC6985
CAS No.:104869-31-0
- (+)-Isopulegol
Catalog No.:BCN4975
CAS No.:104870-56-6
- dl-Aloesol
Catalog No.:BCN7265
CAS No.:104871-04-7
- Borapetoside B
Catalog No.:BCN6593
CAS No.:104901-05-5
- Tranilast Sodium
Catalog No.:BCC4091
CAS No.:104931-56-8
- H-D-Val-OtBu.HCl
Catalog No.:BCC3146
CAS No.:104944-18-5
Synthesis and potency of novel uracil nucleotides and derivatives as P2Y2 and P2Y6 receptor agonists.[Pubmed:18514530]
Bioorg Med Chem. 2008 Jun 15;16(12):6319-32.
The phosphate, uracil, and ribose moieties of uracil nucleotides were varied structurally for evaluation of agonist activity at the human P2Y(2), P2Y(4), and P2Y(6) receptors. The 2-thio modification, found previously to enhance P2Y(2) receptor potency, could be combined with other favorable modifications to produce novel molecules that exhibit high potencies and receptor selectivities. Phosphonomethylene bridges introduced for stability in analogues of UDP, UTP, and uracil dinucleotides markedly reduced potency. Truncation of dinucleotide agonists of the P2Y(2) receptor, in the form of Up(4)-sugars, indicated that a terminal uracil ring is not essential for moderate potency at this receptor and that specific SAR patterns are observed at this distal end of the molecule. Key compounds reported in this study include 9, alpha,beta-methylene-UDP, a P2Y(6) receptor agonist; 30, Up(4)-phenyl ester and 34, Up(4)-[1]glucose, selective P2Y(2) receptor agonists; dihalomethylene phosphonate analogues 16 and 41, selective P2Y(2) receptor agonists; 43, the 2-thio analogue of INS37217 (P(1)-(uridine-5')-P(4)-(2'-deoxycytidine-5')tetraphosphate), a potent and selective P2Y(2) receptor agonist.